Manufacturing: Page 7
-
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES The Rosetta Luminator system, a clientserver bioinformatics system for storing and analyzing microarray data, has been launched by Rosetta Biosoftware and Agilent Technologies Inc. The geneexpression data analysis solution was deve...
By PharmaVoice Team • Jan. 13, 2010 -
Manufacturing for Bio Capacity
George Coleman President, Biomedex Inc., Spokane, Wash.; Biomedex specializes in a broad spectrum of contract manufacturing services for bio- pharmaceutical clients, from regulatory compliance to aseptic filling, to validation, to cleanroom sanitizing agents, to quality assurance, to component cl...
By Denise Myshko • Jan. 11, 2010 -
Trendline
Artificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
Contents
In Every Issue 3 Letter from the Editor 8 Upfront A brief review of industry news at press time 36 Pharma Trax Sales, marketing, and R&D trends from industry analysts 40 What’s New New healthcare-related products, services, and companies 42 E-Media New electronic and Web-based applications, s...
By PharmaVoice Team • Dec. 28, 2009 -
Emerging Markets Poised for Growth
Emerging markets are growing in size and in importance for drug developers. Countries outside the traditional markets of the United States, Europe, and Japan are revamping their regulatory and legal systems and reforming their healthcare systems, and they are expected to contribute more to the gl...
By PharmaVoice Team • Nov. 10, 2009 -
Supply Chain Strategies
Companies need to evaluate their business through their value streams rather than by individual processes or components. ccording to Bob Silvers, managing director, at SSA & Co., by applying the rigors of Lean Six Sigma to underperforming areas, pharmaceutical companies can completely transfo...
By Denise Myshko • Nov. 10, 2009 -
Who's on the List by Company
Acadia Pharmaceuticals Inc. John Kaiser 68 Acorda Therapeutics Inc. Ron Cohen, M.D. 39 Alnylam Pharmaceuticals John Maraganore, Ph.D. 24 AMR Research Hussain Mooraj 107 Amylin Pharmaceuticals Joseph Martinez 76 Astellas Pharma US Charlotte Berlin 64 AVEO Pharmaceuticals Inc. Tuan Ha-Ngoc 20 Avid ...
By PharmaVoice Team • July 29, 2009 -
Contents
12 Commanders & Chiefs These inspirational leaders take charge of their companies’ growth and success by providing a clear vision, developing innovative solutions, and making the tough decisions. 34 The Entrepreneurs Forward-thinking, committed, and dedicated are just the tip of the adjective...
By PharmaVoice Team • July 29, 2009 -
Letter from the Editor
The PharmaVOICE 100: 2009 PharmaVOICE is honored to bring you its fifth annual special issue celebrating 100 of the most inspiring individuals in the life-sciences industry. This issue, which is called the feel-good issue of the year, is packed with in-depth profiles showcasing the industry’s bes...
By Taren Grom • July 29, 2009 -
Letter from the Editor
Help Wanted: Are You Ready for Today’s Job Market? There’s no doubt about it, times are tough. The headlines scream with news about “right sizing," major layoffs due to the economy, and major mergers and acquisitions that are creating redundancies across all functional areas. Even as this issue w...
By Taren Grom • April 23, 2009 -
Talent Pool
Pharmaceutical POOL Dr. Charles BOWDEN Peter TAM Vivus Announces Two Promotions Vivus, a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, has promoted two of its senior executives. Charles Bowden, M.D., has been promoted to senior director, ...
By PharmaVoice Team • March 25, 2009 -
Improving Health Literacy
The statistics are staggering: As many as 90 millions Americans are functionally healthcare illiterate and low health literacy skills cost the U.S.health system about $73 billion.The industry is beginning to school itself in ways to address this national healthcare issue. BY TAREN GROM The health...
By PharmaVoice Team • March 17, 2009 -
Elaine Riddell: Measuring Up
LEADING A MULTIMILLION DOLLAR COMPANY AND ENSURING ITS SUCCESS TAKES SEVERAL KEY CHARACTER TRAITS. Clearly there is a need for vision, courage, and the intelligence to identify personal strengths and weaknesses. Add to this mix a passion for the job to inspire managers and staff. “I don’t know wh...
By PharmaVoice Team • March 17, 2009 -
Navigating New Channels
6 March 2009 VIEW on Advertising THE FORUM Marketers across the board — from sponsor companies to healthcare agencies — are having to accomplish more with fewer resources while finding new ways to address target audiences. “As an industry, we are being asked to do more with less,” says Barry Lee,...
By PharmaVoice Team • March 15, 2009 -
Trials and Tribulations
Clinical trials can provide lifesaving options for some of the more than 60 million critically ill Americans. Yet, due to recent public scrutiny, clinical trials have come under fire based on isolated incidents that have caused some to question the efficacy and safety of trials. According to the ...
By PharmaVoice Team • March 11, 2009 -
Advertising or Patient Safety?
Contributed by Frederick J. Balboni Jr., Executive Director, Consortium for the Advancement of Patient Safety (CAPS) What if all label instructions and warnings suddenly disappeared? Issue Overview In May 2010, the pharmaceutical manufacturing industry may be faced with a daunting change. The Uni...
By Frederick J. Balboni Jr • Feb. 27, 2009 -
Talent Pool
TALENT POOL EXECUTIVE APPOINTMENTS AND PROMOTIONS IN THE HEALTHCARE INDUSTRY Pharma POOL Lamberto ANDREOTTI Dr. Andrew G. BODNAR Donald J. HAYDEN Dr. James B. D. PALMER Thomas J. PICKARD David L. ZABOR Bristol-Myers Squibb Announces New Senior Leadership Team — Appoints Former GlaxoSmithKline V...
By PharmaVoice Team • Feb. 23, 2009 -
Information Technology: Tracking the E-Volution
Pharmaceutical companies have long term plans, they have products that take a long time to develop, a long time to test to gain approval, and they have a shelf life. But technology moves so much faster than that. So the industry as a whole has had to adopt to the speed of technology. IAN CROSS BY...
By PharmaVoice Team • Feb. 21, 2009 -
The Practice of Public Relations
When effectively managed, public relations creates unique opportunities for marketers to provide con sumers and healthcare professionals with immediate and thorough drug and healthcare information. The healthcare publicrelations market in the United States grew 30% last year and is now valued at ...
By PharmaVoice Team • Feb. 21, 2009 -
Letter from the Editor
PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh CONTRIBUTING EDITORS Diane Hoffman Virginia Kirk Denise Myshko Kim Ribbink Deborah Ruriani Copyright 2001 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume One, Number Two PharmaVoice is published six times per yea...
By Taren Grom • Feb. 12, 2009 -
The Green of Going Green
The pharmaceutical industry has made enormous strides to limit its impact on the environment and create projects that improve sustainability. Increasingly, this socially responsible approach also makes good business sense, as more companies are discovering. Doing good and doing well may well be s...
By PharmaVoice Team • Dec. 22, 2008 -
Personalized Medicine
RESEARCH & Development PERSONALIZED MEDICINE The Right Dose at the Right time BY DENISE MYSHKO Obstacles and challenges still remain to make the vision of personalized medicine a reality. Despite some early successes, the development of targeted medicines and pharmacogenomics-based testing ha...
By Denise Myshko • Nov. 22, 2008 -
Development
development RESEARCH & Development BY DENISE MYSHKO Models of CHANGE In the future, successful biopharmaceutical companies will be those that have reviewed R&D business models and implemented updated strategies for improving the development of new products. The pharmaceutical industry is ...
By PharmaVoice Team • Nov. 22, 2008 -
Counterfeit Drugs
Corporate Strategy Counterfeit Drugs Fighting an uphill battle BY DENISE MYSHKO The counterfeit medicines market is a real, clear, and present danger to public health. And while there have been efforts to minimize the threat of counterfeit and substandard medicines, there is a need to coordinate ...
By Denise Myshko • Nov. 22, 2008 -
The Corner Office
Corporate Strategy A review of the annual reports and public statements of more than two dozen of the industry’s publicly traded pharmaceutical/biotechnology companies reveals the top trends as identified by the CEOs, presidents, and executive management teams of these industry standard bearers. ...
By PharmaVoice Team • Nov. 22, 2008 -
Talent Pool
Pharma POOL Dr. Barry Goldstein Merck Appoints Head of Diabetes, Obesity Development Global pharmaceutical company Merck, Whitehouse Station, N.J., has named Barry Goldstein, M.D., Ph.D., FACP, FACE, VP of diabetes and obesity clinical development. In addition to leading overall development of co...
By PharmaVoice Team • Nov. 22, 2008